Document ID: chunk:federal_register_of_legislation:F2023L01175:reg:9:p2
Version: federal_register_of_legislation:F2023L01175
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6695–9022

after the age of 30 years, before the clinical onset of malignant neoplasm of the breast;
(9)          for females only, having smoked tobacco products:
(a)           in an amount of at least 15 pack-years before the clinical onset of malignant neoplasm of the breast; and
(b)          commencing at least 5 years before the clinical onset of malignant neoplasm of the breast; and
if smoking has ceased before the clinical onset of malignant neoplasm of the breast then that onset occurred within 30 years of cessation
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(10)      for females only, consuming alcohol:
             (a)          in an amount of at least 40 kilograms before the clinical onset of malignant neoplasm of the breast; and
             (b)          at least 5 years before the clinical onset of malignant neoplasm of the breast; and
if consumption of alcohol has ceased before the clinical onset of  malignant neoplasm of the breast, then that onset occurred within 40 years of cessation;
Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(11)      inability to undertake any physical activity greater than 3 METs for at least 10  consecutive years within the 30 years before the clinical onset of malignant neoplasm of the breast;
Note: MET is defined in the Schedule 1 – Dictionary.
(12)      for males and postmenopausal females only, being obese for a period of at least 5 years within the 20 years before the clinical onset of malignant neoplasm of the breast;
Note: being obese is defined in the Schedule 1 - Dictionary.
(13)      for death from malignant neoplasm of the breast only, for females aged 50 to 69 years, being prevented from accessing mammographic screening for malignant neoplasm of the breast in accordance with contemporary medical standards at the time, within the 10 years before the clinical onset of malignant neoplasm of the breast, and where:
             (a)          if mammographic screening has been resumed in the interim, there has been no normal test result; and
             (b)          the opportunity for subsequent appropriate mammographic screening has not been declined;
(14)      inability to obtain appropriate clinical management for malignant neoplasm of the breast.